BioHarvest Sciences (BHST)
NASDAQ:BHST
Total Valuation
BioHarvest Sciences has a market cap or net worth of $97.70M. The enterprise value is $65.76M.
Market Cap$97.70M
Enterprise Value$65.76M
Share Statistics
BioHarvest Sciences has 22,667,843 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding22,667,843
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
BioHarvest Sciences’s return on equity (ROE) is -0.44 and return on invested capital (ROIC) is -13.42%.
Return on Equity (ROE)-0.44
Return on Assets (ROA)-0.23
Return on Invested Capital (ROIC)-13.42%
Return on Capital Employed (ROCE)-0.14
Revenue Per Employee396.64K
Profits Per Employee-127.99K
Employee Count87
Asset Turnover0.72
Inventory Turnover3.08
Valuation Ratios
The current PE Ratio of BioHarvest Sciences is ―. BioHarvest Sciences’s PEG ratio is 0.34.
PE Ratio―
PS Ratio2.77
PB Ratio3.75
Price to Fair Value3.75
Price to FCF-9.97
Price to Operating Cash Flow-10.87
PEG Ratio0.34
Income Statement
In the last 12 months, BioHarvest Sciences had revenue of 34.51M and earned -11.13M in profits. Earnings per share was -0.60.
Revenue34.51M
Gross Profit20.48M
Operating Income-5.58M
Pretax Income-11.06M
Net Income-11.13M
EBITDA-6.71M
Earnings Per Share (EPS)-0.60
Cash Flow
In the last 12 months, operating cash flow was -7.30M and capital expenditures -2.38M, giving a free cash flow of -9.68M billion.
Operating Cash Flow-7.30M
Free Cash Flow-9.68M
Free Cash Flow per Share-0.43
Dividends & Yields
BioHarvest Sciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.66
52-Week Price Change-20.19%
50-Day Moving Average4.51
200-Day Moving Average6.94
Relative Strength Index (RSI)45.73
Average Volume (3m)78.84K
Important Dates
BioHarvest Sciences upcoming earnings date is Jun 3, 2026, TBA (Not Confirmed).
Last Earnings DateMar 31, 2026
Next Earnings DateJun 3, 2026
Ex-Dividend Date―
Financial Position
BioHarvest Sciences as a current ratio of 3.97, with Debt / Equity ratio of 55.42%
Current Ratio3.97
Quick Ratio3.38
Debt to Market Cap0.03
Net Debt to EBITDA1.33
Interest Coverage Ratio-2.05
Taxes
In the past 12 months, BioHarvest Sciences has paid 76.00K in taxes.
Income Tax76.00K
Effective Tax Rate>-0.01
Enterprise Valuation
BioHarvest Sciences EV to EBITDA ratio is -12.91, with an EV/FCF ratio of -9.04.
EV to Sales2.51
EV to EBITDA-12.91
EV to Free Cash Flow-9.04
EV to Operating Cash Flow-11.99
Balance Sheet
BioHarvest Sciences has $23.02M in cash and marketable securities with $14.10M in debt, giving a net cash position of $8.92M billion.
Cash & Marketable Securities$23.02M
Total Debt$14.10M
Net Cash$8.92M
Net Cash Per Share$0.39
Tangible Book Value Per Share$1.38
Margins
Gross margin is 59.34%, with operating margin of -16.16%, and net profit margin of -32.27%.
Gross Margin59.34%
Operating Margin-16.16%
Pretax Margin-32.05%
Net Profit Margin-32.27%
EBITDA Margin-19.45%
EBIT Margin-24.16%
Analyst Forecast
The average price target for BioHarvest Sciences is $10.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$10.00
Price Target Upside-11.35% Downside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast45.88%
EPS Growth Forecast43.12%